170161-28-1 Usage
General Description
4,8-bis-(tert-butoxycarbonyl)-1,4,8,11-tetraazacyclotetradecane is a chemical compound with the molecular formula C26H50N4O6. It is a macrocyclic tetraamine derivative that contains four nitrogen atoms and is often used as a chelating agent in coordination chemistry. The compound is commonly used in coordination complexes and metal ion binding studies due to its ability to form stable complexes with metal ions. Additionally, the tert-butoxycarbonyl groups provide protection for the amine nitrogen atoms, making it a versatile compound for various chemical reactions and applications. This chemical compound's unique structure and properties make it an important tool in the field of coordination chemistry and metal ion coordination studies.
Check Digit Verification of cas no
The CAS Registry Mumber 170161-28-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,1,6 and 1 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 170161-28:
(8*1)+(7*7)+(6*0)+(5*1)+(4*6)+(3*1)+(2*2)+(1*8)=101
101 % 10 = 1
So 170161-28-1 is a valid CAS Registry Number.
170161-28-1Relevant articles and documents
Characterization and application of a new diprotected cyclam: A novel two-step synthesis of linked tetraazamacrocycles
Boitrel, Bernard,Andrioletti, Bruno,Lachkar, Mohammed,Guilard, Roger
, p. 4995 - 4998 (1995)
The synthesis and separation of the 1,8-di-(tertbutyloxycarbonyl) cyclam (1,8-diboc cyclam) among other isomers allow the facile obtention of singly or doubly linked, and bridged tetraazamacrocycles within a two-step synthesis in a very convenient way. This strategy can be applied to a large scale preparation of several types of dioxygen carriers or activators.
New bicyclam-AZT conjugates: Design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor
Dessolin, Jean,Galea, Pascale,Vlieghe, Patrick,Chermann, Jean-Claude,Kraus, Jean-Louis
, p. 229 - 241 (2007/10/03)
We report the synthesis of mono- and bis-tetraazamacrocycle-AZT conjugates. All new compounds were screened for their ability to inhibit HIV- 1 replication in MT4 cell line and were compared to AZT alone. It appears that N-protected covalent prodrugs are
